Trial Profile
An open, single-centre, non-controlled study of efficacy, safety and usability of the GlucoTab system for glycaemic management in non-critically ill patients with type 2 diabetes at general wards
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 22 Oct 2013
Price :
$35
*
At a glance
- Drugs Insulin aspart (Primary) ; Insulin glargine (Primary)
- Indications Type 2 diabetes mellitus
- Focus Therapeutic Use
- 19 Oct 2013 Planned number of patients changed from 80 to 100 as reported by European Clinical Trials Database record.
- 07 May 2013 New trial record